
National Health Investors fell 7.2% from $76.72 to $71.23, behind the S&P 500's +10.5%. Its worst day was Apr 22 (−8.2%), and its low came Oct 7 at $63.96.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
National Health Investors closed at its highest level of the year, 18.6% above where the year started.
+1.9% · S&P 500 +0.2%
EPS of $1.22 beat the $0.97 estimate on $105.8M revenue (est. $96.6M); FY EPS guidance of $4.94–$4.99 against the $4.06 consensus.
Story events cover the past 12 months · Times ET
−4.1% · S&P 500 −0.5%
National Health Investors shares fell 8.2%, while the S&P 500 rose 1.0%.
−8.2%, the year's worst day · S&P 500 +1.0%
EPS of $1.23 beat the $1.21 estimate on $115.1M revenue (est. $106.0M); FY EPS guidance of $4.74–$4.79 against the $5.02 consensus.
−3.5% · S&P 500 +0.8%
National Health Investors shares rose 4.4%, while the S&P 500 fell 0.5%.
+4.4%, the year's best day · S&P 500 −0.5%
EPS of $1.19 missed the $1.26 estimate on $121.3M revenue (est. $113.6M); FY EPS guidance of $4.74–$4.79 against the $4.87 consensus.
−5.7% · S&P 500 −0.3%
National Health Investors closed at its lowest level of the year, 16.6% below where the year started.
−2.4% · S&P 500 −0.2%
Where it ended: a close of $71.23 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 25, 2027 (EPS est. $1.16, revenue est. $114.7M).
As of the Nov 9, 2026 close
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NHI and SPY from Benzinga historical bars. Not investment advice.